Silver Book Fact

Visual impairment and blindness cause an annual health utility loss of approximately $10.5 billion. This figure measures lost quality of life when a disease has little or no short-term impact on mortality.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • In a study of new applicants for recent vision loss rehabilitative services, 7% had current major depression and 26.9% met the criteria for subthreshold depression.  
  • One-third of age-related macular degeneration (AMD) patients suffer from clinical depression.  
  • An estimated 1.75 million Americans currently have age-related macular degeneration (AMD). That number is expected to grow to 2.95 million by 2020. * Note that an additional 7.3 million currently…  
  • An estimated 2.3 million Americans 40 and older currently have glaucoma. That number is expected to grow by 50% to 3.36 million by 2020.  
  • Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.